2026. Acquired CD20 Loss as a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma . Mediterranean Journal of Hematology and Infectious Diseases. 18, 1 (Jan. 2026), e2026014. DOI:https://doi.org/10.4084/MJHID.2026.014.